Variability of ticagrelor antiplatelet responsiveness in Chinese ACS patients

被引：0
|
作者：
Yin, Tong [1 ]
Wang, Xuyun [1 ]
Liu, Jia [1 ]
Chen, Yundai [1 ]
机构：
[1] Chinese Peoples Liberat Army, Gen Hosp, Dept Cardiol, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.874
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e0691
引用
收藏
页码：C227 / C227
页数：1
相关论文
共 50 条
  • [41] Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle
    Verdoia, Monica
    Barbieri, Lucia
    De Luca, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 334 : 28 - 29
  • [42] Optimal treatment of ACS patients: Issues and considerations for upstream antiplatelet therapy
    Giri, Satyendra
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 (01) : 19 - 25
  • [43] THE EFFECT OF RACE ON THE ANTIPLATELET EFFECTS OF TICAGRELOR AND ASPIRIN
    Infeld, Margaret
    Friede, Kevin
    Myers, Rachel A.
    Ortel, Thomas
    San, Tan Ru
    Voora, Deepak
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 263 - 263
  • [44] Improved Ticagrelor Antiplatelet Effect on Discontinuation of Phenytoin
    Weeks, Phillip
    Sieg, Adam
    Vandat, Khashayar
    Raissi, Farshad
    Nathan, Sriram
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (05) : 644 - 647
  • [45] Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?
    Cammisotto, Vittoria
    Biondi-Zoccai, Giuseppe
    Frati, Giacomo
    Giordano, Arturo
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (04) : 377 - 379
  • [46] Ticagrelor A Novel Reversible Oral Antiplatelet Agent
    Nawarskas, James J.
    Clark, Sara M.
    CARDIOLOGY IN REVIEW, 2011, 19 (02) : 95 - 100
  • [47] PB 2452 reverses antiplatelet effects of ticagrelor
    Reactions Weekly, 2019, 1746 (1) : 10 - 10
  • [48] Antiplatelet Therapy in Acute Coronary Syndromes: Ticagrelor
    Husted, Steen
    ANTIPLATELET THERAPY IN ACS AND A-FIB, 2012, 47 : 64 - 77
  • [49] Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
    Zhang, Yong
    Chu, Chao
    Zhong, Zhong
    Luo, Yong-bai
    Ning, Fei-Fei
    Guo, Ning
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [50] Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes
    Franzone, Anna
    McFadden, Eugene P.
    Leonardi, Sergio
    Piccolo, Raffaele
    Vranckx, Pascal
    Serruys, Patrick W.
    Hamm, Christian
    Steg, Philippe Gabriel
    Heg, Dik
    Branca, Mattia
    Juni, Peter
    Windecker, Stephan
    Valgimigli, Marco
    EUROINTERVENTION, 2020, 16 (08) : 627 - +
12345